Literature DB >> 15075509

Association of strong virus-specific CD4 T cell responses with efficient natural control of primary HIV-1 infection.

Simone E Gloster1, Philippa Newton, David Cornforth, Jeffrey D Lifson, Ian Williams, George M Shaw, Persephone Borrow.   

Abstract

OBJECTIVE: To investigate whether there are differences in the virus-specific CD4 T cell response during primary HIV-1 infection in patients who naturally (without antiretroviral intervention) control viral replication with differing efficiencies.
METHODS: CD4 T cell responses to recombinant HIV proteins (Gag p24 and p55 and Env gp160) and an inactivated HIV-1 preparation were analysed using interferon-gamma ELISPOT assays (with CD8-depleted peripheral blood mononuclear cells) and by intracellular interferon-gamma staining and fluorescent-activated cell sorting.
RESULTS: Strong HIV-specific CD4 T cell responses were detected from the earliest time-points analysed in primary infection in patients who naturally established low persisting viral loads. By contrast, HIV-specific CD4 T cell responses were weaker (at or just below the limit of detection in our assays) at similar time-points in patients who went on to establish high persisting viral loads. Statistical analysis revealed a highly significant difference (P < 0.001) between the magnitudes of the Gag p24-specific response at the earliest time-point analysed in primary infection in the two sets of patients.
CONCLUSIONS: Strong HIV-specific CD4 T cell responses are associated with efficient natural control of primary HIV-1 infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15075509     DOI: 10.1097/00002030-200403260-00005

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  23 in total

Review 1.  Translating insights from persistent LCMV infection into anti-HIV immunity.

Authors:  Elizabeth B Wilson; David G Brooks
Journal:  Immunol Res       Date:  2010-12       Impact factor: 2.829

2.  Plasmacytoid dendritic cell and functional HIV Gag p55-specific T cells before treatment interruption can inform set-point plasma HIV viral load after treatment interruption in chronically suppressed HIV-1(+) patients.

Authors:  Emmanouil Papasavvas; Andrea Foulkes; Xiangfan Yin; Jocelin Joseph; Brian Ross; Livio Azzoni; Jay R Kostman; Karam Mounzer; Jane Shull; Luis J Montaner
Journal:  Immunology       Date:  2015-05-19       Impact factor: 7.397

3.  Preservation HIV-1-specific IFNγ+ CD4+ T-cell responses in breakthrough infections after exposure to tenofovir gel in the CAPRISA 004 microbicide trial.

Authors:  Marianne W Mureithi; Danielle Poole; Vivek Naranbhai; Shabashini Reddy; Nompumelelo P Mkhwanazi; Sengeziwe Sibeko; Lise Werner; Quarraisha Abdool Karim; Salim Abdool Karim; Thumbi Ndung'u; Marcus Altfeld
Journal:  J Acquir Immune Defic Syndr       Date:  2012-06-01       Impact factor: 3.731

4.  HIV-specific cytolytic CD4 T cell responses during acute HIV infection predict disease outcome.

Authors:  Damien Z Soghoian; Heiko Jessen; Michael Flanders; Kailan Sierra-Davidson; Sam Cutler; Thomas Pertel; Srinika Ranasinghe; Madelene Lindqvist; Isaiah Davis; Kimberly Lane; Jenna Rychert; Eric S Rosenberg; Alicja Piechocka-Trocha; Abraham L Brass; Jason M Brenchley; Bruce D Walker; Hendrik Streeck
Journal:  Sci Transl Med       Date:  2012-02-29       Impact factor: 17.956

5.  Primary HIV-1 Infection: Diagnosis, Pathogenesis, and Treatment.

Authors:  Malini Soogoor; Eric S Daar
Journal:  Curr Infect Dis Rep       Date:  2005-03       Impact factor: 3.725

Review 6.  Primary human immunodeficiency virus type 1 infection.

Authors:  Malini Soogoor; Eric S Daar
Journal:  Curr HIV/AIDS Rep       Date:  2005-06       Impact factor: 5.071

7.  Factors associated with viral rebound in HIV-1-infected individuals enrolled in a therapeutic HIV-1 gag vaccine trial.

Authors:  Jonathan Z Li; Zabrina L Brumme; Chanson J Brumme; Hongying Wang; John Spritzler; Michael N Robertson; Michael M Lederman; Mary Carrington; Bruce D Walker; Robert T Schooley; Daniel R Kuritzkes
Journal:  J Infect Dis       Date:  2011-04-01       Impact factor: 5.226

8.  HIV vaccines: can CD4+ T cells be of help?

Authors:  Eva Van Braeckel; Geert Leroux-Roels
Journal:  Hum Vaccin Immunother       Date:  2012-08-21       Impact factor: 3.452

Review 9.  Mucosal immunology of HIV infection.

Authors:  Huanbin Xu; Xiaolei Wang; Ronald S Veazey
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

10.  Induction of Gag-specific CD4 T cell responses during acute HIV infection is associated with improved viral control.

Authors:  Miriam Schieffer; Heiko K Jessen; Alexander F Oster; Franco Pissani; Damien Z Soghoian; Richard Lu; Arne B Jessen; Carmen Zedlack; Bruce T Schultz; Isaiah Davis; Srinika Ranasinghe; Eric S Rosenberg; Galit Alter; Ralf R Schumann; Hendrik Streeck
Journal:  J Virol       Date:  2014-04-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.